These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Characterization of the RNA silencing suppression activity of the Ebola virus VP35 protein in plants and mammalian cells. Zhu Y; Cherukuri NC; Jackel JN; Wu Z; Crary M; Buckley KJ; Bisaro DM; Parris DS J Virol; 2012 Mar; 86(6):3038-49. PubMed ID: 22238300 [TBL] [Abstract][Full Text] [Related]
8. Crystal structure of human LC8 bound to a peptide from Ebola virus VP35. Lim D; Shin HC; Choi JS; Kim SJ; Ku B J Microbiol; 2021 Apr; 59(4):410-416. PubMed ID: 33630249 [TBL] [Abstract][Full Text] [Related]
9. Purification and functional characterization of the full length recombinant Ebola virus VP35 protein expressed in E. coli. Zinzula L; Esposito F; Mühlberger E; Trunschke M; Conrad D; Piano D; Tramontano E Protein Expr Purif; 2009 Jul; 66(1):113-9. PubMed ID: 19233284 [TBL] [Abstract][Full Text] [Related]
10. The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals. Trunschke M; Conrad D; Enterlein S; Olejnik J; Brauburger K; Mühlberger E Virology; 2013 Jul; 441(2):135-45. PubMed ID: 23582637 [TBL] [Abstract][Full Text] [Related]
11. Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function. Prins KC; Binning JM; Shabman RS; Leung DW; Amarasinghe GK; Basler CF J Virol; 2010 Oct; 84(20):10581-91. PubMed ID: 20686031 [TBL] [Abstract][Full Text] [Related]
12. A simulation investigation on interaction mechanism between Ebola nucleoprotein and VP35 peptide. Ding JN; Zhang YJ; Zhong H; Ao CC; Han JG J Biomol Struct Dyn; 2018 Mar; 36(4):1009-1028. PubMed ID: 28298161 [TBL] [Abstract][Full Text] [Related]
13. dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35. Zinzula L; Esposito F; Pala D; Tramontano E Antiviral Res; 2012 Mar; 93(3):354-63. PubMed ID: 22289166 [TBL] [Abstract][Full Text] [Related]
14. Assembly of the Ebola Virus Nucleoprotein from a Chaperoned VP35 Complex. Kirchdoerfer RN; Abelson DM; Li S; Wood MR; Saphire EO Cell Rep; 2015 Jul; 12(1):140-149. PubMed ID: 26119732 [TBL] [Abstract][Full Text] [Related]
15. Global phosphoproteomic analysis of Ebola virions reveals a novel role for VP35 phosphorylation-dependent regulation of genome transcription. Ivanov A; Ramanathan P; Parry C; Ilinykh PA; Lin X; Petukhov M; Obukhov Y; Ammosova T; Amarasinghe GK; Bukreyev A; Nekhai S Cell Mol Life Sci; 2020 Jul; 77(13):2579-2603. PubMed ID: 31562565 [TBL] [Abstract][Full Text] [Related]
16. Putative endogenous filovirus VP35-like protein potentially functions as an IFN antagonist but not a polymerase cofactor. Kondoh T; Manzoor R; Nao N; Maruyama J; Furuyama W; Miyamoto H; Shigeno A; Kuroda M; Matsuno K; Fujikura D; Kajihara M; Yoshida R; Igarashi M; Takada A PLoS One; 2017; 12(10):e0186450. PubMed ID: 29040311 [TBL] [Abstract][Full Text] [Related]
17. Cellular mRNA triggers structural transformation of Ebola virus matrix protein VP40 to its essential regulatory form. Landeras-Bueno S; Wasserman H; Oliveira G; VanAernum ZL; Busch F; Salie ZL; Wysocki VH; Andersen K; Saphire EO Cell Rep; 2021 Apr; 35(2):108986. PubMed ID: 33852858 [TBL] [Abstract][Full Text] [Related]
18. Serological reactivity of baculovirus-expressed Ebola virus VP35 and nucleoproteins. Groen J; van den Hoogen BG; Burghoorn-Maas CP; Fooks AR; Burton J; Clegg CJ; Zeller H; Osterhaus AD Microbes Infect; 2003 Apr; 5(5):379-85. PubMed ID: 12737993 [TBL] [Abstract][Full Text] [Related]
19. Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection. Yen BC; Basler CF J Virol; 2016 May; 90(10):5108-5118. PubMed ID: 26962215 [TBL] [Abstract][Full Text] [Related]